Advances in pharmacotherapies that target the cell cycle for treatment of breast cancer: where are we at today?-Reference-Cited by-同舟云学术

Advances in pharmacotherapies that target the cell cycle for treatment of breast cancer: where are we at today?

Published:2023-04-12 Issue:8 Volume:24 Page:887-900
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Perrone Martina¹,Giuliani Francesco²,Sanna Valeria³,Bruno Stefania²,Melaccio Assunta²,Santoro Anna Natalizia¹,Laface Carmelo¹,Maselli Felicia Maria¹,Iaia Maria Laura¹,Guarini Chiara¹,Fancellu Alessandro⁴,Fedele Palma¹

Affiliation:

1. Medical Oncology, Dario Camberlingo Hospital, Francavilla Fontana, Puglia, Italy

2. Oncology Unit, San Paolo Hospital, Bari, Puglia, Italy

3. Oncology Unit, Sassari University Hospital, Sassari, Italy

4. Department of Medical, Surgical and Experimental Sciences, Unit of General Surgery, Sassari University Hospital, Sassari, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2023.2201373

Reference110 articles.

1. Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries

2. Cell Cycle Regulation by Checkpoints

3. G 1 Events and Regulation of Cell Proliferation

4. Molecular Pathways: Targeting the Cyclin D–CDK4/6 Axis for Cancer Treatment

5. The retinoblastoma protein and cell cycle control

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DN-ODE: Data-driven neural-ODE modeling for breast cancer tumor dynamics and progression-free survivals;Computers in Biology and Medicine;2024-09

2. The Treatment Landscape of Elderly Patients with Hormone Receptor-Positive Her2 Negative Advanced Breast Cancer: Current Perspectives and Future Directions;Journal of Clinical Medicine;2023-09-16

3. Pyrrolo[2,3-d]pyrimidines as EGFR and VEGFR kinase inhibitors: a comprehensive SAR review;Current Medicinal Chemistry;2023-08-15

4. The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Clinical Application of New Therapeutic Strategies;Pharmaceutics;2023-05-27